Investigator Profile: Jonathan Sham, MD

By Exporter | October 28, 2020

    Investiga tor Profile: Jonathan G. Sham, MD, MBEE President Home » Research Introduction » Research Investigators » Investigator Profile: Jonathan Sham, MD Research Introduction Schilling Lectureship Research Investigators Labs & Centers Bulger Research Group CBATL CBATL Investigators Predictive Analytic Models CBATL Relevant Publications Craniofacial Image Analysis Laboratory (CranIAL) Center for Videoendoscopic Surgery […]

Read More

2021_3_24 Pregnancy Policy – Faculty

By UW Surgery Admin | April 22, 2021

[…] to operate until delivery. 2. Clinic : In general, women faculty are comfortable seeing clinic patients until late in their pregnancy. A gradual slow down, especially of new patients, between the 36 and 40th weeks of pregnancy is recommended, with individual decisions left to the discretion of the surgeon and her OB. Post -operative […]

Read More

Spotlight on Past Trainees

By Michael Hilleary | March 13, 2017

[…] Research Introduction Schilling Lectureship Research Investigators Labs & Centers Bulger Research Group CBATL CBATL Investigators Predictive Analytic Models CBATL Relevant Publications Craniofacial Image Analysis Laboratory (CranIAL) Center for Videoendoscopic Surgery (CVES) CREST HIPRC Mulligan Lab Northwest Liver Research Program (NLRP) VA Research SORCE WISH Resident Research Current Trainees Past Trainees 2021-2023 2020-2022 2019-2021 2018-2020 […]

Read More

Big Lungs, Huge Heart

By UW Surgery Admin | April 24, 2019

UW Medicine | ACCELERATE | April 24, 2019 Brought together by a double-lung transplant, a patient and his surgeon reflect on their connection.   Anyone who’s talked to Coach Shea Little feels compelled to tell you how warm, generous and caring he is. And that kindness is one reason Little means so much to his…

Read More

Dr. Giana Davidson and Research Team Awarded the Donaghue Foundation’s Greater Value Portfolio Grant

By UW Surgery Admin | February 16, 2023
Dr. Giana Davidson

[…] Pharmacy Integrated Transitions (PIT) R01 Randomized Trial. While the PIT program aims to improve coordination between hospitals and skilled nursing facilities (SNFs) by decreasing medication–related problems, this new funding will incorporate the narrative voice of Spanish speaking patients and focus on the transition failures that drive disparate outcomes. Dr. Davidson says, “I am incredibly […]

Read More

surgsynopsis_wtr_2021_22_final_rsch_vascular

By UW Surgery Admin | February 2, 2022

[…] treat due to the high morbidity and mortality associated with the complex procedures needed to treat them. Open operation requires opening the chest and abdomen, various strategies for distal aortic perfusion, aortic cross-clamping, viscero-renal ischemia-reperfusion, and significant blood loss. This is a major undertaking with significant stress to the patient. Endovascular treatment using branched […]

Read More

surgsynopsis_wtr_2021_22_final_rsch_va

By UW Surgery Admin | February 2, 2022

[…] coxsackie adenoviral receptor (CAR) expression could be used as a novel marker to quantitate senescence profiles, and a funded pilot study with Nuclear Medicine colleagues to create new radioligand conjugates to detect in vivo senescent tumors with small animal PET imaging. Using CAR as a surrogate biomarker for senescence, we have shown that senescence […]

Read More

surgsynopsis_wtr_2021_22_final_rsch_sorce

By UW Surgery Admin | February 2, 2022

[…] assumption regarding severity. What are the main findings of CODA so far? On October 25, 2021, the CODA trial team published its longer- term outcomes in the New England Journal of Medicine. These results report on CODA participants at 4 years following their initial treatment (i.e., antibiotics or surgery). Read the full report of […]

Read More

surgsynopsis_wtr_2021_22_final_rsch_hpb

By UW Surgery Admin | February 2, 2022

[…] biorepository, the organotypic models we generate have been adopted by many investigators to explore the behavior of tumors in response to drugs and other perturbagens using the new technology to define dynamic 3D tumor biology. Another component of the HPB research program embraces the conduct of clinical trials to address critical gaps in patient […]

Read More